August 3, 2020 Uncategorized

Rozlytrek, Roche’s first tumour-agnostic therapy, approved in Europe for people with NTRK fusion-positive solid tumours and for people with ROS1-positive advanced non-small cell lung cancer

Rozlytrek has shown durable responses across multiple tumour types, including cancer that has spread to the brain This approval shows the value of combining genomic profiling with precision medicine to offer patients with rare and hard-to-treat cancers a personalised treatment option              Basel, 03 August 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that... Read more

July 23, 2020 Uncategorized

Xylem Watermark donates 40,000 masks to essential water workers in rural communities

Sourcing and donating personal protective equipment to protect frontline workers keeping the water flowing in their communities RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 23, 2020– Xylem Watermark, the corporate citizenship program of global water technology company Xylem Inc. (NYSE: XYL), today announced it is sourcing and donating 40,000 N95 masks to frontline utility operators. The program is... Read more

June 30, 2020 Uncategorized

Probing the Molecules that Control Protein Levels in Your Cells

Fluorescence Correlation Spectroscopy (FCS) provides insights into mRNA binding proteins Proteins are critical for countless roles in our bodies including structure, function, and regulation of our tissues and organs. To create proteins from the genes in our DNA, an intermediate molecule, mRNA, is needed. mRNA is made from DNA in the nucleus and then transported... Read more

June 29, 2020 Uncategorized

Roche’s ENSPRYNG®️ (satralizumab) approved in Japan for adults and children with neuromyelitis optica spectrum disorder

ENSPRYNG is Japan’s first and only approved therapy for both adults and children with neuromyelitis optica spectrum disorder (NMOSD) ENSPRYNG is the first and only approved therapy targeting the interleukin-6 (IL-6) receptor given subcutaneously every four weeks Approval is supported by data demonstrating ENSPRYNG’s robust efficacy, which was well-tolerated with a consistent safety profile, in... Read more

June 16, 2020 Uncategorized

Xylem ranks in Top 20 among 100 Best Corporate Citizens, globally

RYE BROOK, N.Y.–(BUSINESS WIRE)–Jun. 16, 2020– Xylem, a leading global water technology company dedicated to solving the world’s most challenging water issues, has been named one of the 100 Best Corporate Citizens in 3BL Media’s annual ranking of public companies. Xylem ranked 16th in an assessment of 1000 companies globally, rising two places since its... Read more

June 9, 2020 Uncategorized

WITec Begins Expansion of its Headquarters Facility

Increased capacity required to meet growing demand for Raman imaging microscopes Ulm, Germany  June 10th, 2020 WITec GmbH, the technology leader in correlative Raman microscopy, is expanding its headquarters building in Ulm. The new addition will offer more space for production and quality assurance, laboratories for development and customer demonstrations or sample measurements, larger conference... Read more

June 8, 2020 Uncategorized

Pacific Biosciences of California, Inc. Announces Rescheduling of 2020 Annual Meeting of Stockholders and Move to Virtual Meeting

MENLO PARK, Calif., June 08, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Pacific Biosciences of California, Inc. (NASDAQ: PACB) (the “Company”) has announced that it is rescheduling the date of the Company’s 2020 Annual Meeting of Stockholders (the “Annual Meeting”) previously scheduled for Thursday, June 18, 2020, to Tuesday, August 4, 2020, at... Read more